Pfizer and BioNTech SE plan to test the immune response generated by the Omicron-based vaccine both as a three-shot regimen in unvaccinated people and as a booster shot.
Pfizer and BioNTech begin testing Omicron-specific COVID-19 vaccine
© The Crystal Eyes